HomeOpen Access NewsAlzheimer's Disease

Alzheimer's Disease

Using AI to transform parkinson’s diagnosis and care across Europe

Today, on World Parkinson's Day, awareness is raised for people across the EU living with Parkinson's disease.

New blood test could improve detection of Alzheimer’s

A new blood test shows promise in detecting Alzheimer’s as early as 20 years before the onset of cognitive impairment, according to researchers.

Racial discrimination impacts cognitive function in African-American women

Researchers from Boston University, have found that incidents of racial discrimination are associated with lower subjective cognitive function (SCF) among African-American women.

Diabetes significantly increases the risk of developing dementia

Here, Dr Deborah Lee, Dr Fox Online Pharmacy, explores the link between diabetes and the increased risk of developing dementia.

Dementia gene doubles risk of developing severe COVID-19

Researchers at the University of Exeter Medical School and the University of Connecticut School of Medicine found that a faulty gene linked to dementia doubles the risk of developing severe COVID-19.

Chemistry analysis: Microfluidic detection of intracellular nitric oxide levels

Jay Sibbitts, Prof Dr Stefan H. Bossmann and Prof Dr Christopher T. Culbertson, from Kansas State University, Department of Chemistry in the U.S., underline microfluidic detection of intracellular nitric oxide levels.

Alzheimer’s and dementia funding rises in the U.S.

Rachel Conant, Vice President Federal Affairs, Alzheimer’s Association and Alzheimer’s Impact Movement, provides us with an update on Alzheimer’s and dementia funding rises in the United States.

Graph theory in the study of Alzheimer’s disease progression

María J. Peláez1, Prashant Dogra1, Zhihui Wang1, Vittorio Cristini1 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA.

Understanding the difference between Dementia and Alzheimer’s

Ella Hendrix, Writer, takes it back to basics and explains the difference between Dementia and Alzheimer's disease

A brief overview of advances in neurodegenerative diseases

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision Group, provides an overview of Neurodegenerative Diseases.

Vitamin B12 and brain health of older people

Here, Professor Timothy Kwok discusses the impact of vitamin B12 on the brain health of older people.

Data linkage and sharing for healthy longevity: A global challenge

Data linkage and sharing for healthy longevity together present a global challenge, in the view of Prof Makoto Suematsu, Japan Agency for Medical Research and Development and Rihana Diabo at the World Economic Forum.

Hearing loss and the link with dementia

If we address hearing loss, can we really decrease our risk of developing dementia? Mark Atkinson, Chief Executive Action of Hearing Loss investigates.

Intramembrane proteases in neurodegenerative diseases

Prof Dr Regina Fluhrer, from the University of Augsburg, explains how intramembrane proteases have been implicated in the emergence of neurodegenerative diseases.

New health-data programme to detect diseases early

Diseases could be detected even before people experience symptoms, thanks to a pioneering new health-data programme as part of the government’s modern Industrial Strategy.

Virtual reality can spot problems in early Alzheimer’s disease

The University of Cambridge found that virtual reality (VR) can identify early Alzheimer’s disease better than ‘gold standard’ cognitive tests currently in use.

Up to 2 million will live with dementia by 2050

According to the Alzheimer Society 850,000 people in the UK have dementia but with 1 in 6 people over the age of 80 living with dementia, this is predicted to rise to over 2 million by 2050 as the population ages.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders